RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Aortic Valve Damage for the Study of Left-Sided, Native Valve Infective Endocarditis in Rabbits.

Infective endocarditis affects approximately 100,000 individuals in the USA. Medical advances have contributed to the rise of the disease, and no new therapies have emerged in the last 50 years to control the surge of this life-threatening infection. The rabbit vascular physiology and immune response mechanisms are similar to humans. Hence, the rabbit model of infective endocarditis is an excellent research tool with which to address many questions regarding development of endocarditis, for the testing of new therapies, and for the study of the molecular mechanisms used by infectious agents to cause disease. This chapter describes the surgical procedure required to study infective endocarditis in damaged native valves, therefore closely mimicking human disease.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app